ARTICLE | Clinical News
Istodax romidepsin: Phase Ib/II data
December 22, 2014 8:00 AM UTC
An open-label, dose-escalation, French Phase Ib/II trial in 35 evaluable patients with PTCL showed that IV Istodax plus CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine and prednisone) le...